1990—2021年海南省肝硬化疾病负担及其危险因素*

吴宇彤 ,  张东献 ,  周昕竹 ,  邹金婷 ,  耿修来 ,  王兴任 ,  陈赛苦 ,  刘莹 ,  陶俊良

中国卫生统计 ›› 2026, Vol. 43 ›› Issue (3) : 340 -344.

PDF (854KB)
中国卫生统计 ›› 2026, Vol. 43 ›› Issue (3) : 340 -344. DOI: 10.11783/j.issn.1002-3674.2026.03.004
论著

1990—2021年海南省肝硬化疾病负担及其危险因素*

作者信息 +

Disease Burden of Liver Cirrhosis and its Risk Factors in Hainan Province from 1990 to 2021

Author information +
文章历史 +
PDF (874K)

摘要

目的 分析1990—2021年海南省肝硬化疾病负担变化趋势及其影响因素。方法 利用2021年全球疾病负担研究数据,使用Joinpoint回归模型分析1990—2021年海南省居民肝硬化的发病率、死亡率、伤残调整寿命年(disability adjusted life years,DALY)。结果 1990—2021年海南省居民肝硬化的标化发病率为729.81/10万~734.78/10万,平均年度变化百分比(average annual percentage change,AAPC)为-0.03%(t=-0.51,P=0.607),男性和女性AAPC分别为-0.4%(t=-5.85,P<0.001)和0.2%(t=0.91,P=0.365);标化死亡率为8.28/10万~14.75/10万,AAPC为-1.8%(t=-21.11,P<0.001),男性AAPC为-1.3%(t=-11.10,P<0.001),女性AAPC为-3.0%(t=-35.40,P<0.001);标化DALY率为243.71/10万~446.47/10万,AAPC为-1.9%(t=-19.65,P<0.001),女性AAPC为-3.3%(t=-40.66,P<0.001),男性AAPC为-1.41%(t=-10.66,P<0.001);标化过早死亡损失寿命年(years of life lost,YLL)率和标化伤残损失寿命年(years lived with disability,YLD)率均呈现下降趋势,AAPC分别为-1.9%(t=-19.28,P<0.001)和-1.2%(t=-11.29,P<0.001)。在肝硬化疾病负担影响因素中,饮酒导致的DALY的AAPC为1.6%(t=11.27,P<0.001),标化DALY率的AAPC为-1.4%(t=-9.27,P<0.001)。结论 海南省肝硬化疾病负担总体呈下降趋势,饮酒是海南省肝硬化的主要行为危险因素,应加强肝硬化的早诊早治工作。

Abstract

Objective To analyze the change trend of liver cirrhosis disease burden and its influencing factors in Hainan Province from 1990 to 2021.Methods Morbidity,mortality,disability adjusted life years (DALY) of cirrhosis were analyzed from 1990 to 2021 in 2021.Results From 1990 to 2021,the standard incidence of cirrhosis in Hainan residents was 729. 81/10 million to 734. 78/10 million. The average annual percentage change (AAPC) was -0. 03% (t=-0. 51,P=0. 607), AAPC of male was -0. 4% respectively (t=-5. 85,P<0. 001) and female was 0. 2% (t=0. 91,P=0. 365). The standardized mortality rate was 8. 28/10 million to 14. 75/10 million,the AAPC was -1. 8% (t=-21. 11,P<0. 001). Male AAPC was -1. 3% (t=-11. 10,P<0. 001),female AAPC was -3. 0% (t=-35. 40,P<0. 001). The standardized DALY rate is from 243. 71/10 million to 446. 47/10 million,the AAPC was -1. 9% (t=-19. 65,P<0. 001). Female AAPC was -3. 3% (t=-40. 66,P<0. 001),male AAPC was -1. 41% (t=-10. 66,P<0. 001). The rates of standardized years of life lost (YLL) and standardized years lived with disability (YLD) are both decreasing,the AAPC was -1. 9% (t=-19. 28,P<0. 001) and -1. 2%(t=-11. 29,P<0. 001),respectively. Among the influencing factors of cirrhosis,the AAPC was 1. 6% (t=11. 27,P<0. 001),and the AAPC for standardized DALY was -1. 4% (t=-9. 27,P<0. 001).Conclusion The disease burden of cirrhosis in Hainan province is generally decreasing,and drinking alcohol is the main behavioral risk factor for cirrhosis in Hainan Province,so the early diagnosis and treatment of cirrhosis should be strengthened.

关键词

肝硬化 / 疾病负担 / 伤残调整寿命年 / 危险因素 / 海南省

Key words

Cirrhosis / Disease burden / Disability adjusted life years / Risk factors / Hainan Province

引用本文

引用格式 ▾
吴宇彤,张东献,周昕竹,邹金婷,耿修来,王兴任,陈赛苦,刘莹,陶俊良. 1990—2021年海南省肝硬化疾病负担及其危险因素*[J]. 中国卫生统计, 2026, 43(3): 340-344 DOI:10.11783/j.issn.1002-3674.2026.03.004

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Liu Y, Sun Z, Wang Q, et al. Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044 [J].Hepatol Int,2023,17(4):1028-1044.

[2]

Moon AM,Singal AG,Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis [J].Clin Gastroenterol Hepatol,2020,18(12): 2650-2666.

[3]

Loomba R, Friedman SL,Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease [J].Cell,184(10): 2537-2564.

[4]

Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis—aetiology, trends and predictions [J].Nat Rev Gastroenterol Hepatol,2023,20(6): 388-398.

[5]

刘珊山,于晓辉,秦建伟. 1990—2019年中国肝硬化疾病负担变化趋势分析[J].临床肝胆病杂志,2024,40(4):726-733.

[6]

GBD 2021 Demographics Collaborators. Global age—sex—specific mortality,life expectancy,and population estimates in 204 countries and territories and 811 subnational locations, 1950—2021, and the impact of the COVID—19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 [J].Lancet,2024,403(10440): 1989-2056.

[7]

GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries,1990—2021: a systematic analysis for the Global Burden of Disease Study 2021 [J].Lancet,2024,403(10440): 2162-2203.

[8]

GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence,years lived with disability (YLDs),disability—adjusted life—years (DALYs),and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations,1990—2021: a systematic analysis for the Global Burden of Disease Study 2021 [J].Lancet,2024,403(10440): 2133-2161.

[9]

李辉章,杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J].中华预防医学杂志,2020,54(8):908-912.

[10]

海南省卫生厅办公室. 海南省卫生厅办公室关于印发《海南省2006—2010年乙型病毒肝炎防治规划》的通知[Z].2007.

[11]

朱坚. 2010年海南省乙型肝炎监测结果分析[J].海南医学,2011,22(18):128-129.

[12]

石程宾,邱嘉敏,谢佳欣,等. 1990—2019年广东省居民肝硬化疾病负担变化趋势分析[J].中国公共卫生,2025,41(7):823-828.

[13]

连巧龄,吴韶彬,陈亮. 2005—2015年福建省丙型病毒性肝炎流行特征分析[J].中国艾滋病性病,2017,23(1):56-59.

[14]

蒋静,程波,刘继恒. 宜昌市2005—2011年病毒性丙型病毒性肝炎流行动态分析[J].现代预防医学,2013,40(14):2723-2726.

[15]

GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories,1990—2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].Lancet Gastroenterol Hepatol,2020,5(3):245-266.

[16]

尹艳榕,林修全,黄少芬,等. 2005年与2015年福建省肝硬化疾病负担情况分析[J].慢性病学杂志,2019,20(8):1144-1146.

[17]

王小焕,胡锡敏,郭彧,等. 海南省成年居民高血压与心脑血管疾病发病关系前瞻性队列研究[J].中国公共卫生,2019,35(8):986-991.

[18]

孙铭繁,吴梦曼,林昆. 潮汕地区居民吸烟及饮酒情况调查[J].汕头大学医学院学报,2020,33(4):242-246.

[19]

张滔,林国天,林柳婷,等. 海南省中老年人肝功能异常状况及其影响因素分析[J].中华疾病控制杂志,2023,27(6):639-644.

[20]

惠宇,陈碧玉,黄小玲,等. 海南省2011—2019年乙肝流行趋势与特征分析[J].中国热带医学,2022,22(5):412-417.

[21]

Stine JG,Chalasani N. Chronic liver injury induced by drugs: a systematic review [J].Liver Int,2015,35(11): 2343-2353.

[22]

Ganne—Carrié N,Chaffaut C,Bourcier V,et al. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis [J].J Hepatol,2018,69(6): 1274-1283.

[23]

王世越,董晨,常楚迪,等. 中国原发性肝癌基层筛查的机遇与挑战[J].中国全科医学,2023,26(36):4498-4504.

[24]

杜长臻,陈文,王湘君,等. 海南黎族传统黎药发展与传承研究[J].内江科技,2021,42(9):111.

[25]

Meier P,Seitz HK. Age,alcohol metabolism and liver disease [J].Curr Opin Clin Nutr Metab Care,2008,11(1): 21-26.

[26]

World Health Organization. Global status report on alcohol and health 2018[EB/OL]. (2018—09—20) [2023—07—09].https://www.who.int/publications/i/item/9789241565639.

[27]

李镒冲,刘世炜,王丽敏,等. 1990年与2010年中国慢性病主要行为危险因素的归因疾病负担研究[J].中华预防医学杂志,2015,49(4):303-308.

[28]

Huang DQ,Mathurin P,Cortez—Pinto H,et al. Global epidemiology of alcohol—associated cirrhosis and HCC: trends,projections and risk factors [J].Nat Rev Gastroenterol Hepatol,2023,20(1): 37-49.

基金资助

*海南省自然科学基金(823RC501)

海南省哲学社会科学规划项目(HNSK(ZC)25-259)

AI Summary AI Mindmap
PDF (854KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉